In addition, the combination treatment induced great increases in cleaved caspase‐3 and granzyme B compared with the other treatments in CT26‐EV allograft tumours, but these levels were not further enhanced in CT26‐SA14 allograft tumours (Figure 7I and S4C). Here, DDX53 is linked to neoplasm.